Search Results - "Filss, Christian P"

Predicting IDH genotype in gliomas using FET PET radiomics by Lohmann, Philipp, Lerche, Christoph, Bauer, Elena K., Steger, Jan, Stoffels, Gabriele, Blau, Tobias, Dunkl, Veronika, Kocher, Martin, Viswanathan, Shivakumar, Filss, Christian P., Stegmayr, Carina, Ruge, Maximillian I., Neumaier, Bernd, Shah, Nadim J., Fink, Gereon R., Langen, Karl-Josef, Galldiks, Norbert

“…Mutations in the isocitrate dehydrogenase (IDH mut) gene have gained paramount importance for the prognosis of glioma patients. To date, reliable techniques…”
Get full text

Role of O -(2- 18 F-Fluoroethyl)-l-Tyrosine PET for Differentiation of Local Recurrent Brain Metastasis from Radiation Necrosis by Galldiks, Norbert, Stoffels, Gabriele, Filss, Christian P., Piroth, Marc D., Sabel, Michael, Ruge, Maximilian I., Herzog, Hans, Shah, Nadim J., Fink, Gereon R., Coenen, Heinz H., Langen, Karl-Josef

“…The aim of this study was to investigate the potential of O-(2-18F-fluoroethyl)-L-tyrosine (18F-FET) PET for differentiating local recurrent brain metastasis…”
Get full text

Volumetric assessment of recurrent or progressive gliomas: comparison between F-DOPA PET and perfusion-weighted MRI by Cicone, Francesco, Filss, Christian P., Minniti, Giuseppe, Rossi-Espagnet, Camilla, Papa, Annalisa, Scaringi, Claudia, Galldiks, Norbert, Bozzao, Alessandro, Shah, N. Jon, Scopinaro, Francesco, Langen, Karl-Josef

“…Purpose To compare the diagnostic information obtained with 6-[ 18 F]-fluoro- l -3,4-dihydroxyphenylalanine (F-DOPA) PET and relative cerebral blood volume…”
Get full text

Alterations in white matter fiber density associated with structural MRI and metabolic PET lesions following multimodal therapy in glioma patients by Friedrich, Michel, Farrher, Ezequiel, Caspers, Svenja, Lohmann, Philipp, Lerche, Christoph, Stoffels, Gabriele, Filss, Christian P., Weiss Lucas, Carolin, Ruge, Maximilian I., Langen, Karl-Josef, Shah, Nadim J., Fink, Gereon R., Galldiks, Norbert, Kocher, Martin

“…BackgroundIn glioma patients, multimodality therapy and recurrent tumor can lead to structural brain tissue damage characterized by pathologic findings in MR…”
Get full text

Effect of Zolpidem in the Aftermath of Traumatic Brain Injury: An MEG Study by Dammers, Jürgen, Shah, N. Jon, Langen, Karl-Josef, Galldiks, Norbert, Filss, Christian P., Boers, Frank, Rosenberg, Jessica, Sripad, Praveen, Clauss, Ralf

“…In the past two decades, many studies have shown the paradoxical efficacy of zolpidem, a hypnotic used to induce sleep, in transiently alleviating various…”
Get full text

O-(2-[18F]fluoroethyl)-l-tyrosine PET in gliomas: influence of data processing in different centres by Filss, Christian P., Albert, Nathalie L., Böning, Guido, Kops, Elena Rota, Suchorska, Bogdana, Stoffels, Gabriele, Galldiks, Norbert, Shah, Nadim J., Mottaghy, Felix M., Bartenstein, Peter, Tonn, Jörg C., Langen, Karl-Josef

“…Background PET using O -(2-[ 18 F]fluoroethyl)- l -tyrosine ( 18 F-FET) is an established method for brain tumour diagnostics, but data processing varies in…”
Get full text

Radiomics in neuro-oncology: Basics, workflow, and applications by Lohmann, Philipp, Galldiks, Norbert, Kocher, Martin, Heinzel, Alexander, Filss, Christian P., Stegmayr, Carina, Mottaghy, Felix M., Fink, Gereon R., Jon Shah, N., Langen, Karl-Josef

“…•Radiomics is increasingly used and evaluated in patients with brain tumors.•Radiomics extracts additional information from routinely acquired imaging…”
Get full text

Reply: Flare Phenomenon in O -(2-[ 18 F]-Fluoroethyl)-L-Tyrosine PET After Resection of Gliomas by Filss, Christian P, Stegmayr, Carina, Lohmann, Philipp, Galldiks, Norbert, Langen, Karl-Josef

Get full text

Dynamic O-(2-18F-fluoroethyl)-L-tyrosine positron emission tomography differentiates brain metastasis recurrence from radiation injury after radiotherapy by Ceccon, Garry, Lohmann, Philipp, Stoffels, Gabriele, Judov, Natalie, Filss, Christian P, Rapp, Marion, Bauer, Elena, Hamisch, Christina, Ruge, Maximilian I, Kocher, Martin, Kuchelmeister, Klaus, Sellhaus, Bernd, Sabel, Michael, Fink, Gereon R, Shah, Nadim J, Langen, Karl-Josef, Galldiks, Norbert

“…The aim of this study was to investigate the potential of dynamic O-(2-[18F]fluoroethyl)-L-tyrosine (18F-FET) PET for differentiating local recurrent brain…”
Get full text

Clinical applications and prospects of PET imaging in patients with IDH-mutant gliomas by Wollring, Michael M., Werner, Jan-Michael, Ceccon, Garry, Lohmann, Philipp, Filss, Christian P., Fink, Gereon R., Langen, Karl-Josef, Galldiks, Norbert

“…PET imaging using radiolabeled amino acids in addition to MRI has become a valuable diagnostic tool in the clinical management of patients with brain tumors…”
Get full text

Isomers of 4-[18F]fluoro-proline: radiosynthesis, biological evaluation and results in humans using PET by Geisler, Stefanie, Ermert, Johannes, Stoffels, Gabriele, Willuweit, Antje, Galldiks, Norbert, Filss, Christian P, Shah, Nadim J, Coenen, Heinz H, Langen, Karl-Josef

“…Proline and hydroxyproline represent major constituents of mammalian structural proteins, especially of collagen. An efficient radiosynthesis of the…”
Get more information

Sequential implementation of DSC-MR perfusion and dynamic [18F]FET PET allows efficient differentiation of glioma progression from treatment-related changes by Steidl, Eike, Langen, Karl-Josef, Hmeidan, Sarah Abu, Polomac, Nenad, Filss, Christian P., Galldiks, Norbert, Lohmann, Philipp, Keil, Fee, Filipski, Katharina, Mottaghy, Felix M., Shah, Nadim Jon, Steinbach, Joachim P., Hattingen, Elke, Maurer, Gabriele D.

“…Purpose Perfusion-weighted MRI (PWI) and O-(2-[ 18 F]fluoroethyl-)- l -tyrosine ([ 18 F]FET) PET are both applied to discriminate tumor progression (TP) from…”
Get full text

Discrepant MR and [18F]Fluoroethyl-l-Tyrosine PET Imaging Findings in a Patient with Bevacizumab Failure by Galldiks, Norbert, Filss, Christian P., Goldbrunner, Roland, Langen, Karl-Josef

“…Antiangiogenic treatment using bevacizumab may cause difficulties in distinguishing between antivascular and true antitumor effects when using MRI response…”
Get full text

Glutamate Signaling in Patients With Parkinson Disease With REM Sleep Behavior Disorder by Doppler, Christopher E J, Seger, Aline, Farrher, Ezequiel, Régio Brambilla, Cláudia, Hensel, Lukas, Filss, Christian P, Hellmich, Martin, Gogishvili, Ana, Shah, N Jon, Lerche, Christoph W, Neumaier, Bernd, Langen, Karl-Josef, Fink, Gereon R, Sommerauer, Michael

“…Clinical heterogeneity of patients with Parkinson disease (PD) is well recognized. PD with REM sleep behavior disorder (RBD) is a more malignant phenotype with…”
Get full text

Diagnostic Accuracy of MR Spectroscopic Imaging and 18F-FET PET for Identifying Glioma: A Biopsy-Controlled Hybrid PET/MRI Study by Mauler, Jörg, Lohmann, Philipp, Maudsley, Andrew A, Sheriff, Sulaiman, Hoevels, Moritz, Meissner, Anna-Katharina, Hamisch, Christina, Brunn, Anna, Deckert, Martina, Filss, Christian P, Stoffels, Gabriele, Dammers, Jürgen, Ruge, Maximillian I, Galldiks, Norbert, Mottaghy, Felix M, Langen, Karl-Josef, Shah, N Jon

“…Contrast-enhanced MRI is the method of choice for brain tumor diagnostics, despite its low specificity for tumor tissue. This study compared the contribution…”
Get full text

Diagnostic Accuracy of MR Spectroscopic Imaging and 18 F-FET PET for Identifying Glioma: A Biopsy-Controlled Hybrid PET/MRI Study by Mauler, Jörg, Lohmann, Philipp, Maudsley, Andrew A, Sheriff, Sulaiman, Hoevels, Moritz, Meissner, Anna-Katharina, Hamisch, Christina, Brunn, Anna, Deckert, Martina, Filss, Christian P, Stoffels, Gabriele, Dammers, Jürgen, Ruge, Maximillian I, Galldiks, Norbert, Mottaghy, Felix M, Langen, Karl-Josef, Shah, N Jon

“…Contrast-enhanced MRI is the method of choice for brain tumor diagnostics, despite its low specificity for tumor tissue. This study compared the contribution…”
Get full text

Static FET PET radiomics for the differentiation of treatment-related changes from glioma progression by Müller, Marguerite, Winz, Oliver, Gutsche, Robin, Leijenaar, Ralph T. H., Kocher, Martin, Lerche, Christoph, Filss, Christian P., Stoffels, Gabriele, Steidl, Eike, Hattingen, Elke, Steinbach, Joachim P., Maurer, Gabriele D., Heinzel, Alexander, Galldiks, Norbert, Mottaghy, Felix M., Langen, Karl-Josef, Lohmann, Philipp

“…Purpose To investigate the potential of radiomics applied to static clinical PET data using the tracer O-(2-[ 18 F]fluoroethyl)- l -tyrosine (FET) to…”
Get full text

Amino acid PET and MR perfusion imaging in brain tumours by Filss, Christian P., Cicone, Francesco, Shah, Nadim Jon, Galldiks, Norbert, Langen, Karl-Josef

“…Purpose Despite the excellent capacity of the conventional MRI to image brain tumours, problems remain in answering a number of critical diagnostic questions…”
Get full text

Flare Phenomenon in O -(2- 18 F-Fluoroethyl)-l-Tyrosine PET After Resection of Gliomas by Filss, Christian P, Schmitz, Ann K, Stoffels, Gabriele, Stegmayr, Carina, Lohmann, Philipp, Werner, Jan Michael, Sabel, Michael, Rapp, Marion, Goldbrunner, Roland, Neumaier, Bernd, Mottaghy, Felix M, Shah, N Jon, Fink, Gereon R, Galldiks, Norbert, Langen, Karl-Josef

“…PET using -(2- F-fluoroethyl)-l-tyrosine ( F-FET) is useful to detect residual tumor tissue after glioma resection. Recent animal experiments detected reactive…”
Get full text

Putaminal y‐Aminobutyric Acid Modulates Motor Response to Dopaminergic Therapy in Parkinson's Disease by Seger, Aline D., Farrher, Ezequiel, Doppler, Christopher E.J., Gogishvili, Ana, Worthoff, Wieland A., Filss, Christian P., Barbe, Michael T., Holtbernd, Florian, Shah, N. Jon, Fink, Gereon R., Sommerauer, Michael

“…Background Motor response to dopaminergic therapy is a characteristic of patients with Parkinson's disease (PD). Whether nondopaminergic neurotransmitters…”
Get full text